December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Arteriovenous Crossing Dissection for Treatment of Branch Retinal Vein Occlusion
Author Affiliations & Notes
  • DP Han
    Ophthalmology/Retina Med College of WI/Eye Inst Milwaukee WI
  • SR Bennett
    Vitreoretinal Surgery PA Minneapolis MN
  • DF Williams
    Vitreoretinal Surgery PA Minneapolis MN
  • S Dev
    Vitreoretinal Surgery PA Minneapolis MN
  • Footnotes
    Commercial Relationships   D.P. Han, None; S.R. Bennett, None; D.F. Williams, None; S. Dev, None. Grant Identification: Research to Prevent Blindness
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1871. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      DP Han, SR Bennett, DF Williams, S Dev; Arteriovenous Crossing Dissection for Treatment of Branch Retinal Vein Occlusion . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1871.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:: To evaluate arteriovenous (AV) crossing dissection for treatment of branch retinal vein occlusion (BRVO) with secondary macular dysfunction. Methods:Pars plana vitrectomy and dissection of the involved AV crossing site was performed consecutively in 20 eyes of 20 patients with BRVO and macular dysfunction resulting in visual acuity of 20/50 or worse. The overlying retinal artery was dissected free from the retinal surface and separation of the artery and vein at the offending crossing site was attempted. Indications included: macular edema with retinal hemorrhage precluding grid laser treatment (14 eyes), macular edema persisting after previous grid laser treatment (3 eyes), macular edema alone (2 eyes), and macular ischemia (1 eye). Median duration of symptoms was 16 weeks (range 6-156 weeks). Results:In 19 of 20 eyes, the retinal artery was dissected from the retinal surface around the crossing site, but a marked adhesion between artery and vein precluded separation. Operative findings correlated with histologic and cadaver eye studies relating to intervascular adhesion (Seitz; Tang and Han). After a mean follow-up of 10.2 months, VA improved by ≷2 lines in 16 eyes (80%), remained changed in 2 eyes (10%), and worsened by ≷2 lines in 2 eyes (10%). Mean change (+ S.E.) in logMAR was -0.28+.11 (2-3 lines improvement, p=.016) at 1-2 months follow-up and -0.44+.14 (3-4 lines improvement, p=.008) at final follow-up. Preoperative visual acuity was 20/20-20/50 in 5%, 20/60-20/160 in 40%, and 20/200 or worse in 55%. Final visual acuity was 20/20-20/50 in 50%, 20/60-20/160 in 25%, and 20/200 or worse in 25%. Cataract development or worsening was observed in 11 eyes (55%), requiring cataract surgery in 5 eyes (25%). Conclusion:Operative findings of surgical adhesion between retinal artery and vein at proximal arteriovenous crossings in living eyes correlated with previous histologic and cadaver eye studies. Technical aspects of arteriovenous crossing dissection must address this adhesion. Visual improvement may occur after vitrectomy and dissection of the AV crossing without separation of the vessels. A high rate of cataract formation may limit intermediate-term visual outcome.

Keywords: 628 vitreoretinal surgery • 615 vascular occlusion/vascular occlusive disease • 554 retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×